Autopsy report · NCT00609817
Safety and Efficacy Study of GCS-100LE in the Treatment of Multiple Myeloma
Cause of deathFunding or business
“Lack of funding”
Life of this trial
- Registered 4 months before it started.
- Ran for about 11 months before it stopped.
- 9 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 1
- Sponsor
- La Jolla Pharmaceutical Company
- Sponsor type
- Industry
- Conditions
- Multiple Myeloma
- Interventions
- GCS-100; Bortezomib/Dexamethasone
- Participants
- 9
- Sites
- 3
- Countries
- United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.